Achieve Life Sciences Investor Relations Material

Achieve Life Sciences, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to aid in smoking cessation. The company’s lead product candidate is based on cytisinicline, a plant-based alkaloid that is being developed to help people quit smoking by reducing nicotine cravings and withdrawal symptoms. Achieve Life Sciences is engaged in clinical trials to advance its therapeutic offerings aimed at addressing nicotine addiction. The company is headquartered in Seattle, United States, and its shares are listed on the NASDAQ.